Several other pathways are also capable of being activated by the CD44v in breast cancer, for example, CD44v6 induce hypoxia-inducible factor 1α (HIF1α) so as to increase rate of glycolysis [14]. This evidence concerns the gene HIF1A and breast carcinoma.